Letter to the Editor “assessing the performance of virus-mimic nanoparticles against other nano-drug delivery systems in efficiency, biocompatibility, and patient results”

•Innovative virus-like nanoparticles boost drug delivery effectiveness and biocompatibility.•Virus-mimic nanoparticles enhance GI tract navigation and drug absorption.•Studies confirm the biocompatibility and safety of virus-mimic nanoparticles.•Further research needed on VMNs' long-term effects and clinical viability.•VMNs may improve patient outcomes by increasing oral drug bioavailability.